2031 年骨关节炎治疗市场规模、份额和趋势

Publication Month : Feb 2024

  • Report Code : TIPRE00038936
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 199
Inquire Before Buy

PRICING

$5190

$4152

【研究报告】骨关节炎治疗市场规模预计将从2022年的173.5864亿美元增长到2030年的306.761亿美元;预计 2022-2030 年市场复合年增长率为 7.4%。

市场洞察和分析师观点:

骨关节炎治疗市场预测可以帮助该市场的利益相关者规划其增长战略。骨关节炎是最常见的关节炎类型,主要影响中老年人。骨关节炎通常影响手、臀部、脊柱或膝盖,是由关节软骨破裂和关节周围骨质过度生长引起的。物理干预,如物理治疗和锻炼、口服和外用药物、关节注射和外科手术都是骨关节炎治疗和治疗的一部分。骨关节炎患病率的上升和创新治疗方案的出现减少了对药物的依赖,推动了市场的发展。然而,产品召回阻碍了骨关节炎治疗市场的增长。

增长动力:

骨关节炎患病率上升推动骨关节炎治疗

在全球范围内,骨关节炎影响着超过 5 亿人,占根据疾病预防控制中心的报告,占世界人口的 7%。它是长期残疾的主要原因。骨关节炎在运动员和遭受关节损伤或创伤的人中更为普遍。此外,女性更为常见,占全球骨关节炎病例的 60%。根据世界卫生组织(WHO)的报告,骨关节炎在老年人群中更为普遍。此外,骨关节炎可能影响任何人,但这种情况最常见于 40 岁及以上的成年人。此外,世界卫生组织的报告进一步显示,约73%的人口年龄超过55岁,患有骨关节炎,其中60%是女性。根据美国疾病控制与预防中心 (CDC) 的报告,美国有超过 3250 万成年人受到 OA 的影响。因此,随着 OA 患病率的上升,生物疗法等新的治疗选择正在全世界范围内受到关注。富血小板血浆 (PRP) 疗法是一种有前景的 OA 治疗方法。 PRP 通过催化身体的自然愈合和组织修复过程来增强组织恢复。

因此,骨关节炎患病率的上升促进了对治疗药物的需求,从而影响了骨关节炎治疗市场的增长。

创新治疗选择减少对药物的依赖

非药物治疗是治疗 OA 的一个关键方面。随着生活方式的改变和药物的使用,骨关节炎患者可能会受益于各种支持性治疗方案,包括热袋或冷袋以及辅助装置。此外,营养补充剂和发红剂等补充和替代疗法可能有助于治疗骨关节炎。此外,局部治疗、监督锻炼、神经肌肉训练、自我管理、患者教育和减肥干预是适合 OA 的最佳治疗方法。

在骨关节炎膝关节疼痛 (OKP) 治疗中,使用护膝减轻膝盖疼痛,因为这些支架可能会对软组织施加压力,稳定膝盖并重新分配重量。护膝的一些例子是压缩套、铰接护膝和卸载护膝。此外,这些压缩支架可以在药店、药房和在线渠道轻松买到。因此,创新治疗方案的可用性减少了对药物的依赖,从而推动了骨关节炎治疗市场的增长。

战略见解

报告细分和范围:

“骨关节炎治疗市场”分析”已通过考虑以下细分市场进行:治疗类型、疾病适应症和最终用户。

细分分析:

按治疗类型,骨关节炎治疗市场细分为经皮电治疗神经刺激 (TENS)、职业治疗、物理治疗、富血小板血浆 (PRP) 治疗和基质血管分数、增殖疗法等。物理治疗细分市场在 2022 年占据最大的市场份额,预计该细分市场在预测期内复合年增长率最高,为 7.7%。

瑜伽等物理治疗有助于改善受影响患者的身体机能由膝骨关节炎引起。临床研究表明,与接受糖皮质激素注射的患者相比,接受物理治疗(PT)的膝骨关节炎患者获得了更多的质量调整生命年。此外,物理治疗在临床上比糖皮质激素注射更有效;此外,它被认为是一种更具成本效益的选择。

可以通过在线资源获得针对骨关节炎的物理治疗课程,特别是在 COVID-19 大流行等危机情况下。此外,通过在线干预的会议可以以低成本或免费的方式吸引广泛的受众。患者可以根据自己的舒适度和便利性在家中参加虚拟会议。物理治疗的上述好处将为预测期内的骨关节炎治疗市场提供利润丰厚的机会。

骨关节炎治疗市场,按疾病适应症 - 2022 年和 2030 年

骨关节炎治疗市场,按疾病指示,分为仪表和附件。膝骨关节炎细分市场将在 2022 年占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 7.7% 的最高水平。根据美国国家科学院的报告,膝骨关节炎(KO)占总疾病负担的80%以上,每年影响近19%的45岁及以上的美国成年人。制造商推出创新产品有助于减轻膝骨关节炎的负担。 2021 年 9 月,Contura International Ltd 宣布推出新产品“Arthrosamid”,这是当前疗法的替代品,可满足安全、有效、长效和微创治疗缓解膝关节骨关节炎相关疼痛的未满足的临床需求。因此,膝关节骨关节炎的患病率不断上升,以及减少骨关节炎疼痛的创新产品的推出,推动了骨关节炎治疗市场的增长。

骨关节炎治疗市场,按最终用户划分,分为医院和诊所、专科诊所、门诊手术中心 (ASC)、家庭护理等。家庭护理领域在 2022 年占据最大的市场份额,医院和诊所领域预计在预测期内复合年增长率最高,达到 7.5%。克服关节炎的首要方法是减少多余的体重。此外,热疗法和冷疗法可以使僵硬的关节恢复灵活性,从而有助于减轻关节疼痛。事实证明,使用电热毯或湿热垫有助于减轻疼痛。然而,可以对受影响的关节进行冷处理,例如冰袋或冷冻蔬菜袋,以缓解疼痛。事实证明,此类治疗方案的可用性是在家治疗骨关节炎的成功疗法,这推动了家庭护理领域骨关节炎治疗市场的增长。

骨关节炎治疗市场趋势

更有效的治疗方案推动骨关节炎治疗加速骨关节炎治疗市场扩张

目前,骨关节炎尚无治愈方法。一组临床研究科学家通过临床试验透露,他们正在开发可以阻止 OA 进展的创新治疗目标选择。 2021年11月,LG化学公司宣布启动下一代治疗关节炎新药的临床试验。此外,该公司还宣布获得韩国食品药品安全部的批准,基于治疗骨关节炎的新候选药物“LG00034053”的积极临床前结果启动 1b/2 期临床试验。此外,2021年10月,Pacira BioSciences, Inc.宣布收购 Flexion Therapeutics 以治疗非阿片类疼痛管理“ZILRETTA”。该药物于 2017 年获得批准,是第一个也是唯一一个获得批准的利用缓释微球技术治疗 OA 膝关节疼痛的药物。

2023 年 9 月,Sorrento Therapeutics, Inc. 宣布该药物的 2 期顶线临床试验结果积极“树脂毒素(RTX)计划”。该 2 期试验是一项多中心、双盲、安慰剂和主动对照研究,评估 RTX 多个剂量组治疗中重度 OAK 患者疼痛的有效性和安全性。此外,Sorrento 决定在当前的临床试验方案中纳入一种已获批准的竞争药物“Zilretta”。

区域分析:

从地理上看,全球骨关节炎治疗市场报告分为北美洲、欧洲、亚太地区、南美洲和中美洲、中东和非洲。 2022年,北美拥有最大的骨关节炎治疗市场份额。美国是北美市场的最大贡献者。根据美国疾病控制与预防中心 (CDC) 报告中披露的统计数据,骨关节炎 (OA) 是最常见的关节炎形式,影响着美国 3250 万成年人。此外,骨关节炎 (OA) 行动联盟报告显示,美国每年与 OA 相关的总体经济负担估计为 1,368 亿美元。此外,美国伦琴射线协会 ARRS 报告显示,OA 的终生风险为 50%,预计到 2040 年,该国约有 7800 万 (26%) 成年人将患有 OA。

进一步制造商批准的针对骨关节炎疼痛非药物疗法的新产品进一步影响了骨关节炎治疗市场的增长。 2021 年 6 月,CyMedica Orthopaedics 宣布“Intellihab 系统”获得 FDA 批准,这是一种治疗膝骨关节炎疼痛的无创疗法。此次推出的新产品是一个基于数字的治疗生态系统,旨在治疗骨关节炎疼痛和衰弱性骨关节炎疾病。因此,旨在减少 OA 治疗中对疗法的依赖的新非药物疗法将在预测期内推动骨关节炎治疗市场的增长。

行业发展和未来机遇:

一些下面列出了骨关节炎治疗市场领先企业的战略发展:

2022 年 3 月,Vision Quest Industries Inc. 宣布推出新产品“OActive Align 骨关节炎护膝”。 OActive Align 骨关节炎护膝为临床医生提供了一种简单的解决方案,可定制和对齐支架,以实现卓越的患者治疗效果。该支架提供了独特的功能组合,可对齐支架铰链轴,精确贴合解剖结构,并将其固定在最有效的位置以缓解疼痛。2023 年 10 月,DePuy Synthes Inc. 宣布 FDA 批准“TriALTIS 脊柱系统”以及 TriALTISTM 导航仪器。” TriALTIS Spine 系统和 TriALTISTM 导航支持仪器是先进的仪器和广泛的植入物组合,TriALTIS Spine 系统是可与支持技术集成的下一代后胸腰椎椎弓根螺钉系统。 TriALTIS 导航仪器的示例包括可手动或通电用于导航和非导航应用的钻头、丝锥和螺丝刀。竞争格局和主要公司:

Vision Quest Industries Inc, Dr PRP USA LLC、Estar Technologies Ltd、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc、Medi GmbH & Co KG 和 Zealmax Innovations Pvt Ltd 是骨关节炎治疗市场报告中介绍的知名公司之一。这些公司专注于开发新技术、升级现有产品并扩大其地域分布,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the osteoarthritis therapy market across the globe?

Key factors that are driving the growth of this market are rising prevalence of osteoarthritis and reducing dependency on medications are expected to boost the market growth for the osteoarthritis therapy over the years.

Which are the top companies that hold the market share in osteoarthritis therapy market?

Zimmer Biomet Holdings, Inc. and Bioventus Inc are the top two companies that hold huge market shares in the osteoarthritis therapy market.

Which region is expected to witness significant demand for osteoarthritis therapy market in the coming years?

Global osteoarthritis therapy market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the osteoarthritis therapy market in 2022.

What is osteoarthritis therapy?

Osteoarthritis is the most common type of arthritis, mostly affects middle-aged and older persons. Osteoarthritis, which usually affects the hands, hips, spine, or knees, is caused by a breakdown in joint cartilage and an overgrowth of bone surrounding the joint. Physical intervention, such as physical therapy and exercise, oral and topical drugs, joint injections, and surgical procedures to treat severely damaged joints are all part of osteoarthritis treatment and therapy.

What is the market CAGR value of osteoarthritis therapy market during forecast period?

The CAGR value of the osteoarthritis therapy market during the forecasted period of 2022-2030 is 7.4%.

Which disease indication segment leads the osteoarthritis therapy market?

The knee osteoarthritis segment held the largest share of the market in the global osteoarthritis therapy market and held the largest market share in 2022.

Which therapy type held the largest share in the osteoarthritis therapy market?

The others segment dominated the global osteoarthritis therapy market and held the largest market share in 2022.

Who are the key players in the osteoarthritis therapy market?

The osteoarthritis therapy market majorly consists of the players such Vision Quest Industries Inc, Dr PRP USA LLC, Estar Technologies Ltd, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, Medi GmbH & Co KG, and Zealmax Innovations Pvt Ltd, and amongst others.

The List of Companies - Osteoarthritis Therapy Market

  1. Vision Quest Industries Inc             
  2. Dr PRP USA LLC   
  3. Estar Technologies Ltd     
  4. Zimmer Biomet Holdings Inc          
  5. DePuy Synthes Inc             
  6. Bioventus Inc       
  7. Omron Healthcare Inc      
  8. Exactech Inc         
  9. Medi GmbH & Co KG        
  10. Zealmax Innovations Pvt Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports